Sam H. Sternberg | AIChE

Important Notice: Limited Web Access September 17 to 19, 2021

AIChE will undertake a routine upgrade of our digital infrastructure this weekend between 4pm ET Friday afternoon and 4pm ET Sunday afternoon. During this period access to all services that require login or payment will be limited.

Sam H. Sternberg

Assistant Professor
Columbia University

Samuel H. Sternberg, PhD, runs a research laboratory at Columbia University, where he is an assistant professor in the Department of Biochemistry and Molecular Biophysics. He received his B.A. in Biochemistry from Columbia University in 2007, graduating summa cum laude, and his Ph.D. in Chemistry from the University of California, Berkeley in 2014. After a brief book-writing stint, Sam worked as a Scientist and Group Leader at Caribou Biosciences, a start-up biotechnology company that develops genome engineering technologies, before beginning his independent position at Columbia in 2018.

Sam's doctoral research in the laboratory of Howard Hughes Medical Institute Investigator Dr. Jennifer Doudna focused on the mechanism of DNA targeting by RNA-guided bacterial immune systems (CRISPR-Cas) and on the development of these systems for genome engineering applications. He earned graduate student fellowships from the National Science Foundation and the Department of Defense, and was awarded the Scaringe Award from the RNA Society and the Harold Weintraub Graduate Student Award from the Fred Hutchinson Cancer Research Center. His laboratory is continuing research into the functions of CRISPR–Cas systems, and more broadly, strives to expand our understanding of the ways in which noncoding RNAs conspire with effector proteins to manipulate genetic information.

Sam is also a strong believer in science communication and outreach. In addition to presenting often to non-technical audiences, he recently co-authored a popular science trade book together with Jennifer Doudna, entitled "A Crack in Creation", about the discovery, development, and applications of CRISPR gene-editing technology.